Early Access

Published: 24 September 2024

Online Version of Records before inclusion in an issue

These are newly published articles but not yet assigned to an issue. The Early Access service lets users access peer-reviewed articles well before publication in a regular issue. These articles are searchable and citable by their DOI (Digital Object Identifier).

Original Articles

A comprehensive evaluation of the transition to a biosimilar of adalimumab in rheumatoid arthritis and psoriatic arthritis: a single-center experience with a focus on imaging outcomes

Rodrigo Garcia-Salinas, Sebastian Magri, Alvaro Ruta, Santiago Ruta

https://doi.org/10.4081/reumatismo.2025.1748

98

PDF: 29
- PDF
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro

https://doi.org/10.4081/reumatismo.2025.1817

730

PDF: 199

SUPPLEMENTARY MATERIAL: 83
- PDF
- SUPPLEMENTARY MATERIAL
Prevalence of musculoskeletal disorders in patients referred for suspected deep vein thrombosis: insights from a rheumatologist-led clinic

Nikoletta Svendsen, Philip Rask Lage-Hansen, Stavros Chrysidis

https://doi.org/10.4081/reumatismo.2025.1828

705

PDF: 106
- PDF
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

https://doi.org/10.4081/reumatismo.2025.1694

1322

PDF: 362
- PDF
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease

Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

https://doi.org/10.4081/reumatismo.2025.1744

1021

PDF: 169

SUPPLEMENTARY MATERIAL: 81
- PDF
- SUPPLEMENTARY MATERIAL

Reviews

The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment

Zahra Rodgarpoor, Ahmad Meshkin, Mohammadamin Ehramianpour, Fateme Zare

https://doi.org/10.4081/reumatismo.2025.1753

494

PDF: 131
- PDF
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

https://doi.org/10.4081/reumatismo.2025.1754

909

PDF: 265

SUPPLEMENTARY MATERIAL: 84
- PDF
- SUPPLEMENTARY MATERIAL
Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

https://doi.org/10.4081/reumatismo.2025.1718

775

PDF: 285

SUPPLEMENTARY MATERIAL: 79
- PDF
- SUPPLEMENTARY MATERIAL

Case Reports

Tuberculosis infection in patients with dermatomyositis

Luis Carlos Palomino Romero, Alfredo Vargas Caselles, Natalia Soledad Rius, Enrique Soriano, Javier Rosa, Marina Scolnik

https://doi.org/10.4081/reumatismo.2025.1631

540

PDF: 155
- PDF
Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

Maria Iacovantuono, Chiara Bonini, Ernesto Di Biase, Vinicio Magliacani, Gian Domenico Sebastiani

https://doi.org/10.4081/reumatismo.2025.1756

725

PDF: 177
- PDF
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

https://doi.org/10.4081/reumatismo.2025.1682

854

PDF: 231
- PDF

Letters to the Editor

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

Ciro Manzo, Marco Isetta

https://doi.org/10.4081/reumatismo.2025.1823

1016

PDF: 186
- PDF

Viewpoints

To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody- associated vasculitis and giant cell arteritis

Alessandro Tomelleri, Christian Dejaco, Milena Bond

https://doi.org/10.4081/reumatismo.2025.1791

854

PDF: 251
- PDF

Current Issue

Early Access

Original Articles

A comprehensive evaluation of the transition to a biosimilar of adalimumab in rheumatoid arthritis and psoriatic arthritis: a single-center experience with a focus on imaging outcomes

Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Prevalence of musculoskeletal disorders in patients referred for suspected deep vein thrombosis: insights from a rheumatologist-led clinic

Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease

Reviews

The role of leukemia inhibitory factor in autoimmune disorders: insights into recovery and treatment

Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

Case Reports

Tuberculosis infection in patients with dermatomyositis

Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors

Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Letters to the Editor

After what time interval are we justified to diagnose immune checkpoint inhibitor-mediated polymyalgia rheumatica?

Viewpoints

To prophylax or not to prophylax? The role of trimethoprim/sulfamethoxazole as a prophylactic agent in systemic vasculitis: the case of antineutrophil cytoplasmic antibody- associated vasculitis and giant cell arteritis

authors

reviewers

Categories

indexing

Keywords